1,108 filings
PX14A6G
Tara Health Foundation
16 Apr 24
Letter to shareholders
10:19am
DEFA14A
PFE
Pfizer Inc.
11 Apr 24
Additional proxy soliciting materials
11:00am
DEFA14A
PFE
Pfizer Inc.
11 Apr 24
Additional proxy soliciting materials
10:59am
DEFA14A
PFE
Pfizer Inc.
11 Apr 24
Additional proxy soliciting materials
10:57am
DEFA14A
PFE
Pfizer Inc.
9 Apr 24
Additional proxy soliciting materials
10:29am
DEFA14A
0glq0xa
28 Mar 24
Additional proxy soliciting materials
4:19pm
DEFA14A
tdh5f
28 Mar 24
Additional proxy soliciting materials
4:10pm
ARS
n3d5d0q7e7zx
14 Mar 24
Annual report to shareholders
9:12am
DEFA14A
jzf9c3 17hd32jp
14 Mar 24
Additional proxy soliciting materials
9:07am
S-3ASR
orlq55b45o550
23 Feb 24
Automatic shelf registration
4:34pm
S-8
51bkg32nfja011fgk
23 Feb 24
Registration of securities for employees
4:33pm
8-K
yjh15fkc
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
8-K
szlu543s2ijmn1i1941
10 Jan 24
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
4:38pm
8-K/A
zyfq1
14 Dec 23
Pfizer Completes Acquisition of Seagen
5:04pm
8-K
ptswowe5ie53ne 40
14 Dec 23
Pfizer Completes Acquisition of Seagen
7:51am
8-K
yqi1fz4wzfb9gli rb
13 Dec 23
Full-Year 2024 Revenue Guidance(1) Range of $58.5 to $61.5 Billion Includes Expected Contribution from Seagen Acquisition
7:44am
8-K
5jcxej azbhzup78bv
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm